Methyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-5-carboxylate

Catalog No. :
ACIFFN664
CAS No. :
1020243-01-9
Molecular Formula :
C13H10N2O5
Molecular Weight :
274.23

IUPAC Name:methyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-5-carboxylate

Methyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00Login to see priceInquiryInquiry
1g95%$388.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-5-carboxylate
IUPAC Namemethyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-5-carboxylate
MDL No.MFCD12033724
Molecular FormulaC13H10N2O5
Molecular Weight274.23
SMILESO=C(C1=CC=C(OC(N2CC3=NOC=C3)=O)C2=C1)OC
InChI KeyAXXTVNHXBFDUAH-UHFFFAOYSA-N
Synonymmethyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydro-1,3-benzoxazole-5-carboxylate;MFCD12033724;Methyl 3-(isoxazol-3-ylmethyl)-2-oxo-2,3-dihydrobenzo[d]oxazole-5-carboxylate;5-Benzoxazolecarboxylic acid, 2,3-dihydro-3-(3-isoxazolylmethyl)-2-oxo-, methyl ester
CAS No.1020243-01-9

Synthetic Route by SureRoute

1. ACIFFN664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRLWO321 route compound structure diagram
    ACRLWO32165422-70-0 In Stock
  2. Plus
  3. ACZBMU069 route compound structure diagram
    ACZBMU06957684-71-6 In Stock
  4. Then
  5. ACIFFN664 route product structure diagram
    ACIFFN6641020243-01-9
Inquiry

2. ACIFFN664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFVGQ196 route compound structure diagram
    ACFVGQ19676632-20-7 In Stock
  2. Plus
  3. ACRLWO321 route compound structure diagram
    ACRLWO32165422-70-0 In Stock
  4. Then
  5. ACIFFN664 route product structure diagram
    ACIFFN6641020243-01-9
Inquiry

Comments (0)